Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Berry

Showing results (131-140 of 697) with videos related to

Pageof 70
Sort By:
Cardiovascular Research|October 21, 2025
One-dimensional virtual fractional flow reserve: promise, pragmatism, and next stepsRobert A Sykes, Dylan Tan, Colin Berry
European Heart Journal|June 28, 2023
Novel therapy for ischaemia with no obstructive coronary arteriesAndrew J Morrow, Richard McFarlane, Colin Berry
European Heart Journal|May 27, 2017
Coronary artery disease: physiology and prognosisThomas J Ford, David Corcoran, Colin Berry
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 2, 2012
Myocardial repair and regeneration: bone marrow or cardiac stem cells?Keith G Oldroyd, Colin Berry, Jozef Bartunek
Heart (British Cardiac Society)|October 15, 2017
Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic needThomas J Ford, David Corcoran, Colin Berry
European Heart Journal|September 1, 2024
Bail-out glycoprotein IIb/IIIa inhibitors for coronary microvascular obstruction: guideline-indicated, but does harm outweigh benefit?Jasmine Latter, Peter J McCartney, Colin Berry
International Journal of Technology Assessment in Health Care|December 3, 2013
Are value of information methods ready for prime time? An application to alternative treatment strategies for NSTEMI patientsSeamus Kent, Andrew Briggs, Simon Eckermann, et al.
Journal of the American Heart Association|August 12, 2020
Pooled Analysis of Bleeding, Major Adverse Cardiovascular Events, and All-Cause Mortality in Clinical Trials of Time-Constrained Dual-Antiplatelet Therapy After Percutaneous Coronary InterventionJohn D McClure, Jennifer C Ramsay, Colin Berry
European Heart Journal|August 27, 2023
Coronary revascularization guided by instantaneous wave-free ratio compared with fractional flow reserve: pooled 5-year mortality in the DEFINE-FLAIR and iFR-SWEDEHEART trialsColin Berry, John D McClure, Keith G Oldroyd
Circulation|October 4, 2017
Meta-Analysis of Death and Myocardial Infarction in the DEFINE-FLAIR and iFR-SWEDEHEART TrialsColin Berry, John D McClure, Keith G Oldroyd
Pageof 70

Showing results (131-140 of 697) with videos related to

Sort By:
Pageof 70
Cardiovascular Research|October 21, 2025
One-dimensional virtual fractional flow reserve: promise, pragmatism, and next stepsRobert A Sykes, Dylan Tan, Colin Berry
European Heart Journal|June 28, 2023
Novel therapy for ischaemia with no obstructive coronary arteriesAndrew J Morrow, Richard McFarlane, Colin Berry
European Heart Journal|May 27, 2017
Coronary artery disease: physiology and prognosisThomas J Ford, David Corcoran, Colin Berry
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 2, 2012
Myocardial repair and regeneration: bone marrow or cardiac stem cells?Keith G Oldroyd, Colin Berry, Jozef Bartunek
Heart (British Cardiac Society)|October 15, 2017
Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic needThomas J Ford, David Corcoran, Colin Berry
European Heart Journal|September 1, 2024
Bail-out glycoprotein IIb/IIIa inhibitors for coronary microvascular obstruction: guideline-indicated, but does harm outweigh benefit?Jasmine Latter, Peter J McCartney, Colin Berry
International Journal of Technology Assessment in Health Care|December 3, 2013
Are value of information methods ready for prime time? An application to alternative treatment strategies for NSTEMI patientsSeamus Kent, Andrew Briggs, Simon Eckermann, et al.
Journal of the American Heart Association|August 12, 2020
Pooled Analysis of Bleeding, Major Adverse Cardiovascular Events, and All-Cause Mortality in Clinical Trials of Time-Constrained Dual-Antiplatelet Therapy After Percutaneous Coronary InterventionJohn D McClure, Jennifer C Ramsay, Colin Berry
European Heart Journal|August 27, 2023
Coronary revascularization guided by instantaneous wave-free ratio compared with fractional flow reserve: pooled 5-year mortality in the DEFINE-FLAIR and iFR-SWEDEHEART trialsColin Berry, John D McClure, Keith G Oldroyd
Circulation|October 4, 2017
Meta-Analysis of Death and Myocardial Infarction in the DEFINE-FLAIR and iFR-SWEDEHEART TrialsColin Berry, John D McClure, Keith G Oldroyd
Pageof 70